Literature DB >> 9218157

Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leukaemia.

R J Frewin1, D Provan, A G Smith.   

Abstract

The purine analogue, fludarabine, is of proven efficacy in the treatment of lymphoid malignancies. The drug appears to be well tolerated with minimal side-effects, and few toxicities have been observed. A case of myelodysplasia occurring after therapy with fludarabine is presented and its implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218157     DOI: 10.1046/j.1365-2257.1997.00229.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  2 in total

1.  Irreversible marrow aplasia after single course of 2-chlorodeoxyadenosine for hairy cell leukaemia preceding by A pandemic 2009-H1N1-associated pneumonia.

Authors:  Grzegorz Helbig; Krzysztof Woźniczka; Agata Wieczorkiewicz; Jacek Pająk; Sławomira Kyrcz-Krzemien
Journal:  Med Oncol       Date:  2010-07-23       Impact factor: 3.064

Review 2.  Achieving optimal outcomes in chronic lymphocytic leukaemia.

Authors:  T J Hamblin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.